SEC Filing · 6-K
Clearmind Medicine Inc.
CMNDNASDAQEQUITYCurrent
SEC Filing
Company context
Clearmind is a clinical-stage neuroplastogens pharmaceutical biotech company focused on the discovery and development of non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements.
Current securities
Historical securities (1)
As-filed source
As filedOpen full document ↗